Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ACTRIMS 2022 | Cognitive involvement in MS – the importance

Leigh Charvet • 26 Feb 2022
ACTRIMS 2022
Multiple Sclerosis and Related Disorders

Leigh Charvet, PhD, New York University Grossman School of Medicine, New York, NY, talks about cognitive involvement in multiple sclerosis (MS) and how it proves to be a major impairment towards many patients who suffer from the disease. Being a common symptom in the MS community, issues with everyday life are expected – leading to the need to develop further home-based, accessible treatments for those affected. This interview took place at the ACTRIMS Forum 2022 in West Palm Beach, Florida.

Disclosures

Prof. Charvet reports the following disclosures:
Funding: US Department of Defense & National Multiple Sclerosis Society

More from Leigh Charvet

5:12
Transcranial direct current stimulation to decrease cannabis use in MS
Leigh Charvet • 23 Feb 2024
9:21
Developments in teleinterventions: tDCS with remote supervision for MS rehabilitation
Giuseppina Pilloni et al. • 13 Apr 2022
1:00
How does tDCS work in MS?
Leigh Charvet • 26 Feb 2022
1:10
The potential of non-invasive brain stimulating therapies in negating the adverse symptoms of MS
Leigh Charvet • 26 Feb 2022

Related Videos

5:02
Differential immune cell modulation with highly vs moderately efficacious DMTs in MS
Shane Arsenault • 14 Apr 2024
1:59
Exciting remyelination research in MS: cell therapy and neuromodulation
Giancarlo Comi • 23 Mar 2024
2:30
The potential of wearables for continuous activity monitoring in MS
Giancarlo Comi • 23 Mar 2024
3:19
Is MS progressive from onset? Challenging the classical understanding of progression
Giancarlo Comi • 23 Mar 2024
The content of VJNeurology is intended for healthcare professionals